Cite
Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks.
MLA
Kang, S., et al. “Tazarotene Cream for the Treatment of Facial Photodamage: A Multicenter, Investigator-Masked, Randomized, Vehicle-Controlled, Parallel Comparison of 0.01%, 0.025%, 0.05%, and 0.1% Tazarotene Creams with 0.05% Tretinoin Emollient Cream Applied Once Daily for 24 Weeks.” Archives of Dermatology, vol. 137, no. 12, Dec. 2001, pp. 1597–604. EBSCOhost, https://doi.org/10.1001/archderm.137.12.1597.
APA
Kang, S., Leyden, J. J., Lowe, N. J., Ortonne, J. P., Phillips, T. J., Weinstein, G. D., Bhawan, J., Lew-Kaya, D. A., Matsumoto, R. M., Sefton, J., Walker, P. S., & Gibson, J. R. (2001). Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks. Archives of Dermatology, 137(12), 1597–1604. https://doi.org/10.1001/archderm.137.12.1597
Chicago
Kang, S, J J Leyden, N J Lowe, J P Ortonne, T J Phillips, G D Weinstein, J Bhawan, et al. 2001. “Tazarotene Cream for the Treatment of Facial Photodamage: A Multicenter, Investigator-Masked, Randomized, Vehicle-Controlled, Parallel Comparison of 0.01%, 0.025%, 0.05%, and 0.1% Tazarotene Creams with 0.05% Tretinoin Emollient Cream Applied Once Daily for 24 Weeks.” Archives of Dermatology 137 (12): 1597–1604. doi:10.1001/archderm.137.12.1597.